Sarada Gurubhagavatula is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gurubhagavatula is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Gurubhagavatula is currently accepting new patients.

Frederic J. Scoopo, MD, is a pulmonologist specializing in pulmonary disease and critical care medicine with Atlantic Medical Group (AMG). Board-certified in internal medicine with subspecialties in pulmonary disease and critical care medicine by the American Board of Internal Medicine, he has over 25 years of experience treating disorders of the lungs and respiratory system, including interstitial lung disease, chronic obstructive pulmonary disease, asthma, and bronchiectasis. He is dedicated to providing compassionate, personalized care to all patients, and making sure they are educated about their condition and treatment.After earning his medical degree from the University of Connecticut School of Medicine, Farmington, CT, Dr. Scoopo performed a residency in internal medicine and pediatrics at Morristown Memorial Hospital, Morristown, NJ, where he also served as chief resident. He then completed a fellowship in pulmonary and critical care medicine at Hahnemann University School of Medicine, Philadelphia, PA. He has served as medical intensive care unit director at Morristown Medical Center, chair of the Pharmacy and Therapeutics Committee at Morristown Medical Center, and currently serves as a clinical assistant professor at Rutgers New Jersey Medical School. He also holds a BS in chemistry, magna cum laude, from Villanova University, Villanova, PA. He has authored peer-reviewed publications, is a member of the professional organizations the American Thoracic Society and the American College Chest Physicians, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Scoopo is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Nodules, Lung Metastases, Pulmonary Fibrosis, and Chronic Obstructive Pulmonary Disease (COPD).

Dr. Mark Widmann is chief of Thoracic Surgery at Morristown Medical Center and leads Atlantic Medical Group’s North Jersey Thoracic Surgical Associates. Board certified in thoracic surgery, Dr. Widmann offers expert subspecialty surgical care to patients with benign and malignant disorders of the lung, mediastinum, pleura, esophagus and chest wall. He has expertise in state-of-the-art, minimally-invasive techniques and has led the programs development of Video-Assisted Thoracic Surgery (VATS) and other endoscopic/laparoscopic approaches to treat conditions such as cancer, infection, pneumothorax and swallowing disorders.With a commitment to clinical excellence, Dr. Widmann leads the section of thoracic surgery at Morristown Medical Center and has been surgical director of the Lung Cancer Program at Atlantic Health’s Carol G. Simon Cancer Center since 2000. Dr. Widmann graduated magna cum laude from Duke University and went on to pursue his medical degree at Yale University School of Medicine. His post-graduate training includes NIH sponsored research fellowships in Cardiovascular disease at Yale and the University of Iowa Hospitals. He performed his residency training in general surgery at Yale-New Haven Hospital in New Haven, CT and cardiothoracic residency training at the University of Iowa Hospitals & Clinics in Iowa City, IA.Committed to resident education, Dr. Widmann serves as an assistant clinical professor of surgery at Columbia University College of Physicians and Surgeons in New York. He is a member of the Society of Thoracic Surgeons and a fellow of the American College of Surgeons and the American College of Chest Physicians and former president of the NJ Society of Thoracic Surgeons. Dr. Widmann is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Fibrosing Mediastinitis, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Endoscopy.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Erwin Oei is a Pulmonary Medicine provider in Cedar Knolls, New Jersey. Dr. Oei is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Metastases, Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), and Lung Nodules. Dr. Oei is currently accepting new patients.

Najah Doka is an Infectious Disease provider in Cedar Knolls, New Jersey. Dr. Doka is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Sepsis, Pneumonia, COVID-19, and Bacterial Gastroenteritis. Dr. Doka is currently accepting new patients.

Fazila Aslam is an Infectious Disease provider in Cedar Knolls, New Jersey. Dr. Aslam is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Sepsis, Lymphangitis, Cellulitis, and Pneumonia. Dr. Aslam is currently accepting new patients.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.

Karim R. Saab, MD, is a fellowship-trained hematology oncology specialist with Atlantic Medical Group Hematology Oncology. Triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine, Dr. Saab has years of teaching experience and clinical knowledge.After graduating with distinction from the School of Medicine at the American University of Beirut, Lebanon, Dr. Saab served as a research scholar and postdoctoral research fellow in the Department of Surgery at St. Jude Children’s Research Hospital, Memphis, TN, followed by two years as a postdoctoral research fellow at Harvard Medical School, Brigham and Women’s Hospital, and Children’s Hospital Boston, Transplantation Research Center, Boston, MA. He performed his residency in internal medicine at the University of Colorado, Aurora, CO, where he was awarded the internal medicine resident research publication award, followed by a fellowship in hematology and medical oncology at Weill Cornell Medical College / New York-Presbyterian Hospital, New York, NY.Before joining Atlantic Medical Group Hematology Oncology, Dr. Saab worked at Hennepin Healthcare in Minneapolis, MN, where he also served as assistant professor of medicine at the University of Minnesota. Dr. Saab has been involved in teaching hematology and medical oncology fellows, residents, medical and physician assistant students, as well as teaching medical students at Weill Cornell Medical College. Actively involved in research, Dr. Saab has studied biomarkers for diagnosis, disease progression and response to therapy; cancer stem cell biology; and antiangiogenic therapy for solid tumors. He has been published in many peer-reviewed journals and presented at national conferences.Dr. Saab is an active member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians, and American Physician Scientists Association. He is fluent in French and Arabic. Dr. Saab is a participating provider of the Atlantic Accountable Care Organization. Dr. Saab is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Federico Steiner, MD, is a board-certified thoracic surgeon at Atlantic Medical Group, Morristown Medical Center, and he is the chief of Thoracic Surgery at Overlook Medical Center. With extensive expertise in thoracic surgical oncology, he takes a multidisciplinary approach, collaborating closely with medical and radiation oncologists to ensure each patient receives the highest-quality, comprehensive care.Dr. Steiner is board-certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery and specializes in robotic-assisted and minimally invasive thoracoscopic procedures. He incorporates the latest technologies, including intraoperative molecular imaging, to help identify small tumors and treat complex diseases within the chest cavity, including cancers of the lung and esophagus, as well as conditions affecting the trachea, mediastinum and chest wall. He also performs a range of procedures, including hiatal and paraesophageal hernia repairs, hyperhidrosis surgery and esophageal and airway stenting, ensuring patients benefit from the most advanced and effective surgical care available.Known for his calm and compassionate approach, Dr. Steiner takes the time to listen, respond to questions and explain health issues in a way patients can easily understand. Knowledgeable and attentive, he applies his exceptional surgical skills and more than 25 years of experience to help patients heal and move forward following treatment. He is also dedicated to teaching residents and medical students, sharing his expertise and passion for advancing the field of thoracic surgery through education and mentorship.Dr. Steiner earned his medical degree from New York University Grossman School of Medicine and completed his residency and fellowship in cardiothoracic surgery at New York University Medical Center. He also completed two years of surgical oncology research fellowship at the National Cancer Institute, focusing on lung cancer, esophageal cancer, and mesothelioma. He has consistently been named a “Top Doctor” in numerous publications, including Jersey’s Best magazine, New York magazine, and Castle Connolly Top Doctors. He is fluent in Spanish and is a participating provider of the Atlantic Accountable Care Organization. Dr. Steiner is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Thymic Epithelial Tumor, Pleuropulmonary Blastoma, Lung Nodules, Advanced Bronchoscopy, and Thymectomy.

Advanced practice nurse, Tara Beach, is a member of North Jersey Thoracic Surgical Associates located at Morristown Medical Center. She is an acute care nurse practitioner certified by the American Nurses Credentialing Center, and she provides compassionate care for adults and children who are dealing with conditions of the heart and lungs. Tara attended Georgetown University for her post-graduate education. Ms. Beach is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Nodules and ALK-Positive Non-Small Cell Lung Cancer.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Rachel Hutchins is a Nurse Practitioner in Morristown, New Jersey. Ms. Hutchins is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, and Pulmonary Fibrosis. Ms. Hutchins is currently accepting new patients.

Ashley Day is a Physician Assistant in Morristown, New Jersey. Ms. Day is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Smoldering Multiple Myeloma, ALK-Positive Non-Small Cell Lung Cancer, Classical Hodgkin Lymphoma, and Febrile Neutropenia. Ms. Day is currently accepting new patients.

Advanced practice nurse, Edgar LaChica, is part of the AMG Hospitalist team at Morristown Medical Center. He is certified by the American Nurses Credentialing Center and has extensive clinical knowledge caring for cancer patients. Dr. LaChica attended Walden University for his post-graduate education and he applies critical analysis and evidence-based decision making to achieve optimal outcomes. Mr. Lachica is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer and Heart Failure with Preserved Ejection Fraction (HFpEF).

Jaimin Shah is a Radiologist and an Interventional Radiologist in Morristown, New Jersey. Dr. Shah has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Ascites, Familial Pancreatic Cancer, Lung Cancer, Liver Embolization, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

David Gallinson is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gallinson is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is currently accepting new patients.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).